Form 4: Zimmer Biomet Director Syed A. Jafry Reports Acquisition of Phantom Stock Units

Director Syed A. Jafry reports acquiring phantom stock units in Zimmer Biomet Holdings, Inc. under the Deferred Compensation Plan for Non-Employee Directors.

Summary

• Syed A. Jafry, a director of Zimmer Biomet Holdings, Inc., filed a Form 4 on July 2, 2024, reporting a transaction that occurred on June 30, 2024.
• The transaction involved the acquisition of 126.751 phantom stock units under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.
• The conversion or exercise price of each derivative security is 1-for-1.
• The phantom stock units were accrued at a price of $108.48 per unit.
• Following the reported transaction, Jafry directly owns 5,854.171 shares of common stock.
• The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard compensation practices and alignment of director interests with the company's performance.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• The Deferred Compensation Plan for Non-Employee Directors is a common practice to attract and retain qualified board members.

Future Outlook

The units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Industry Context

This filing is a routine disclosure related to director compensation and is typical for publicly traded companies. Deferred compensation plans are common in the industry to align director interests with shareholder value.

Comparison to Industry Standards

• Deferred compensation plans for non-employee directors are a common practice among publicly traded companies, including Zimmer Biomet's competitors such as Stryker, Johnson & Johnson (DePuy Synthes), and Medtronic.
• These plans typically involve granting phantom stock units or similar instruments that vest over time and are settled in cash or stock upon the director's departure from the board.
• The specific terms of these plans, such as the vesting schedule, settlement method, and valuation of the units, can vary depending on the company's compensation policies and practices.

Stakeholder Impact

• The acquisition of phantom stock units by a director can positively impact shareholders by aligning the director's interests with the company's long-term success.
• Employees may view this as a positive sign of management's commitment to the company.

Key Dates